SkinnyRx review: pricing, fine print, and how it ranks

The price, in words

On tirzepatide, SkinnyRx prices out at $299 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. That ranks #8 of 17 priced compounded programs — $84 a month above the field's floor (NexLife at $215). Semaglutide runs $199 a month all-in. (#10 of 19 on our semaglutide basis)

What the fine print says

Portions of the record were recorded from third-party round-ups rather than a SkinnyRx pricing page we could capture in full. Confirm the flat rate and dose coverage at checkout. Conflict note: a competing comparison site reported SkinnyRx tirzepatide at $129/mo (May 2026); the figure we could verify at our capture is $299 flat. We rank only what we can read at the source and flag the discrepancy until re-capture.

Pharmacy & transparency

Price evidence: Source-verified, last verified 2026-08-05. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

The dose ladder, priced rung by rung

The ladder is the easiest math in SkinnyRx's favor: $299 at 2.5 mg, $299 at 5, $299 at 7.5, $299 at 10, and $299 at 12.5 and 15 — one number, six rungs. The practical consequences compound over a treatment course: the standard four-month climb to 10 mg costs exactly $1,196 (four flat months, no arithmetic), a post-plateau escalation from 10 to 12.5 mg is clinically free, and holding a dose an extra month for tolerability — the standard side-effect play — changes nothing on the bill. Against dose-scaled competitors whose entry figures climb 40–75% by maintenance, and against Zepbound's $299→$449 steps, a flat ladder means the advertised number is the number you keep paying.

What the first year actually bills

Twelve months at the maintenance basis puts SkinnyRx's first-year spend at $3,588 — twelve identical charges of $299, titration included, because the flat structure makes month one and month twelve the same line item. No prepaid tier is published, so the standing rate is the only rate — simpler, and fully flexible. Benchmarked to the verified floor, the year costs $1,008 more than NexLife's $2,580 — the premium a buyer should be able to name a reason for. Brand context: Zepbound's comparable first year via LillyDirect runs about $5,188 on a standard titration, and $5,388 for a full year already at maintenance.

The 24-month view

Stretch the horizon to 24 months — a realistic treatment arc for a maintenance therapy — and SkinnyRx's standing-rate ledger reads $7,176. The same 24 months cost $5,160 at the verified floor and $10,776 on brand Zepbound at maintenance — bookends worth writing on the first invoice.

The semaglutide side of the house

Semaglutide here runs $199/month all-in, ranking #10 of 19 on our verified semaglutide basis — against a field floor of $133 (Oak Longevity, with state limits) and brand Wegovy's flat $349. The in-house premium for stepping up to tirzepatide is $100/month — the local price of SURMOUNT-5's 20.2%-vs-13.7% head-to-head result, and a switch that stays inside one program's intake and pharmacy relationships.

Where it sits in the market

On the verified tirzepatide board, SkinnyRx's $299 all-in rate ranks #8 of 17: $84/month above the NexLife floor; one rung cheaper sits OrderlyMeds at $299 (a $0/mo gap); one rung pricier is Amble Health at $300. Against the FDA-approved benchmark, the same year costs $1,800 less than Zepbound's $449 maintenance tier — the discount a buyer is accepting compounded-product risk to collect. The full board, sortable and dated, is the tirzepatide ranking.

Three buyers, priced honestly

The week-one starter. First month at the 2.5 mg rung: $299 — same as every later month on the flat plan. The 10 mg maintainer. Settled at maintenance, the run-rate is $299/month, $3,588/year — the figure that should anchor any comparison, since it describes years two and three, not the promo. The prepay optimizer. No prepaid tier exists here; the committed-money crowd should compare Found's $169 and NexLife's $186 twelve-month effectives instead.

Nearest alternatives at this price point

If this program's terms don't fit, the same money buys SkinnyRx at $299 (flat at every dose, no membership); Amble Health at $300 (flat at every dose, no membership); Found at $289 (flat at every dose, no membership, prepaid to $169) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

SkinnyRx publishes availability of: not published. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the all-in monthly price at 10 mg and at 12.5 mg, in writing, including every mandatory fee; (2) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (3) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit SkinnyRx — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

SkinnyRx sits mid-pack on tirzepatide price. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.